MARKET

SCNX

SCNX

Scienture Holdings, Inc
NASDAQ
0.3267
+0.0304
+10.26%
Pre Market: 0.3200 -0.0067 -2.05% 09:14 04/07 EDT
OPEN
0.3078
PREV CLOSE
0.2963
HIGH
0.3370
LOW
0.2881
VOLUME
28.21K
TURNOVER
0
52 WEEK HIGH
2.600
52 WEEK LOW
0.2382
MARKET CAP
13.27M
P/E (TTM)
-0.1208
1D
5D
1M
3M
1Y
5Y
1D
SCIENTURE PROVIDES ANNUAL SHAREHOLDER UPDATE, OUTLINING SIGNIFICANT PROGRESS AND STRATEGIC PRIORITIES FOR THE YEAR AHEAD
Reuters · 1d ago
Weekly Report: what happened at SCNX last week (0330-0403)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 03/30 17:05
BUZZ-U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar
Reuters · 03/30 15:53
Scienture Holdings Posts Strong Revenue Growth For 2025; Stock Down
NASDAQ · 03/30 15:50
Scienture Holdings, Inc. GAAP EPS of -$2.70, revenue of $0.43M
Seeking Alpha · 03/30 13:23
Scienture FY25 operating loss widens to $42.6 million; gross margin climbs 7,240 bps to 76.8%
Reuters · 03/30 12:10
*Scienture Holdings 2025 Loss/Shr $2.70 >SCNX
Dow Jones · 03/30 12:09
More
About SCNX
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.

Webull offers Scienture Holdings Inc stock information, including NASDAQ: SCNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCNX stock methods without spending real money on the virtual paper trading platform.